Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intimal Medial Thickness of Internal Carotid Artery”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Large-scale testing (Phase 3)Study completedNCT01534533
What this trial is testing

Effects of Lutein Supplementation on Subclinical Atherosclerosis

Who this might be right for
Carotid AtherosclerosisCarotid Intimal Medial Thickness 1
Peking University 192
Not applicableActive Not RecruitingNCT02694094
What this trial is testing

Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy

Who this might be right for
HypercholesterolemiaCarotid Intimal Medial Thickness 1Seizure+5 more
Johns Hopkins University 105
Testing effectiveness (Phase 2)Study completedNCT02347813
What this trial is testing

Preventing Squamous Cell Skin Cancer

Who this might be right for
Squamous Cell Carcinoma of the Skin
University of Rochester 12
Not applicableUnknownNCT01752244
What this trial is testing

Assessing the Effects of Alfacalcidol Intake on Expression of Involed Gene in Metabolism in Obese Subjects

Who this might be right for
Obesity
Tehran University of Medical Sciences 94
Not applicableUnknownNCT05123287
What this trial is testing

A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

Who this might be right for
Plaque, AtheroscleroticImmune Checkpoint InhibitorsProgrammed Cell Death Protein 1 Inhibitor+2 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Early research (Phase 1)Study completedNCT00638560
What this trial is testing

Changes of Biomarkers in Response to Training and Antioxidant Treatment

Who this might be right for
ObesityType 2 Diabetes
University of Leipzig 40
Testing effectiveness (Phase 2)Study completedNCT00575471
What this trial is testing

Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Daiichi Sankyo Co., Ltd. 250
Not applicableStudy completedNCT02902016
What this trial is testing

Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies

Who this might be right for
Lactose Intolerance
University Hospital, Lille 22
Testing effectiveness (Phase 2)Study completedNCT00013598
What this trial is testing

Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

Who this might be right for
Fatty LiverNonalcoholic Steatohepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Not applicableStudy completedNCT03072342
What this trial is testing

PERIODONTITIS AND VASCULAR DYSFUNCTION

Who this might be right for
PeriodontitisIntimal Medial Thickness of Internal Carotid Artery
University College, London 190
Post-approval studies (Phase 4)Study completedNCT00145340
What this trial is testing

Pioglitazone Treatment in Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Odense University Hospital 30